The principal aims of the partners’ meeting held in Leiden (The Netherlands), on November 16th-17th, 2011 were to proceed with the finalization of the studies protocols, to discuss patient recruitment details and other studies modifications according to the apporved PIP and include them in an updated TA as well as to sign the new Consortium Agreement.